Skip Navigation



JAC Advance Access published online on May 26, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki176
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
56/1/154    most recent
dki176v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mattie{dagger}, H.
Right arrow Articles by van Dissel, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattie{dagger}, H.
Right arrow Articles by van Dissel, J. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org
Received April 9, 2005
Accepted April 20, 2005

Original article

Pharmacodynamics of antibiotics with respect to bacterial killing of and release of lipoteichoic acid by Streptococcus pneumoniae

Herman Mattie{dagger} 1, Kristin Stuertz 2, Roland Nau 2, and Jaap T. van Dissel 1*

1 Department of Infectious Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
2 Department of Neurology, University of Göttingen, Göttingen, Germany

* To whom correspondence should be addressed.
Jaap T. van Dissel, E-mail: j.t.van_dissel{at}lumc.nl


  Abstract

Objectives: There are marked differences in the amount of immunoreactive components such as lipoteichoic acid (LTA) released from Gram-positive bacteria following exposure to different antibiotics. Little is known about the kinetics and amount of release of such components in relation to bacterial killing.

Methods: Bacterial killing and LTA release from Streptococcus pneumoniae type 3 during exposure to ceftriaxone, meropenem, rifampicin, rifabutin, quinupristin/dalfopristin, and trovafloxacin in tryptic soy broth were quantified microbiologically and by ELISA, respectively. We applied a mathematical model to characterize quantitatively the amount of lipoteichoic acid released and the statistical moments of this release.

Results: The model approach revealed that (i) the lag time to release of LTA was very similar for individually killed bacterial cells (~120 min), whatever the killing mechanism effected by the antibiotic, and (ii) the amount of LTA released per killed bacterial cell, a value that we regard as an indicator of the relation between antibacterial efficacy and possible adverse immunostimulatory effects due to release of cell wall components, differs markedly between antibiotics, even at antibiotic concentrations inducing equal killing. Rifamycins were most effective in killing S. pneumoniae while causing the least LTA release per killed bacterial cell; the amount released was about one-half that by quinupristin-dalfopristin and trovafloxacin, and one-quarter that by ceftriaxone and meropenem.

Conclusions: In the evaluation of antibacterial drugs, the present model provides useful information on the whole process of bacterial killing and release of immunoreactive components from the bacterial cell wall.

Keywords: S. pneumoniae; LTA; immunostimulatory components.
{dagger} Deceased.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
D. Grandgirard, C. Schurch, P. Cottagnoud, and S. L. Leib
Prevention of Brain Injury by the Nonbacteriolytic Antibiotic Daptomycin in Experimental Pneumococcal Meningitis
Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2173 - 2178.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
H. S. Seo, J. H. Kim, and M. H. Nahm
Platelet-Activating Factor-Acetylhydrolase Can Monodeacylate and Inactivate Lipoteichoic Acid
Clin. Vaccine Immunol., April 1, 2006; 13(4): 452 - 458.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.